The DOI matches its Crossref record.
Altering the Progression of Human Alveolar Bone Loss With the Non‐Steroidal Anti‐Inflammatory Drug Flurbiprofen
Abstract
T he treatment of human periodontal diseases relies on mechanical and antimicrobial suppression of the etiologic bacteria. The ability to alter the progression of Periodontitis by additionally blocking host pathways involved in the destructive process is an area of current research. Prostaglandins and other metabolites of arachidonic acid are believed to be important host mediators of the bone resorption of diseases such as Periodontitis. We have previously examined the effect of inhibitors of Prostaglandin production, non‐steroidal antiinflammatory drugs (NSAIDs), on inhibiting alveolar bone loss in beagles. The present study was designed to examine the effect of the NSAID, flurbiprofen, on slowing the radiographic loss of alveolar bone in the human. Fifty‐six individuals with radiographic evidence of alveolar bone loss were recruited for study. Forty‐four patients remained in the study for the data analysis of loss of alveolar bone. Following a 6 month baseline pretreatment period to measure the radiographic progression of bone loss, half of the patients were administered flurbiprofen, 50 mg. b.i.d., while half were administered a placebo. All patients received a subgingival scaling and pumice by a hygienist every 6 months. The rate of alveolar bone loss in a 2‐year treatment period was compared to the baseline 6 month pretreatment period within and between patient groups. Throughout the study, teeth exhibiting obvious loss of bone were exited from study and treated with conventional mechanical therapy. At the end of the pretreatment period both patient groups had a similar mean rate of alveolar bone loss. In individuals given placebo tablets, the rate of bone loss was significantly (P <.05) less than baseline at 6 and 12 months of treatment, but not thereafter. Individuals given flurbiprofen twice daily had a significant (P <.05) decrease in rate of bone loss compared to baseline at 6, 12 and 18 months of treatment. In addition we found that at 12 and 18 months of flurbiprofen use the rate of bone loss in the flurbiprofen treated individuals was significantly less than in the placebo patients. However at 24 months of the treatment period there was no difference in the rate of bone loss between the placebo and flurbiprofen treated patients. These data suggest that the NSAID flurbiprofen, as an inhibitor of cyclooxygenase, can inhibit human alveolar bone loss as measured radiographically. This finding suggests that pharmacologic agents whose main action is the blocking of host responses involved in the disease process may become adjuncts to anti‐infective therapy in the management of bone resorption diseases such as Periodontitis. (J Periodontol 1989;60:485–490)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Williams, R. C. (1990) · New England Journal of Medicine · doi:10.1056/nejm199002083220606 · Cited by 482
Self-citationBlockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice
Lalla, E., Lamster, I. B., Feit, M., Huang, L., Spessot, A., Qu, W., Kislinger, T., Lu, Y., Stern, D. M., & Schmidt, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8942 · Cited by 375
Lessons learned and unlearned in periodontal microbiology
Teles, R., Teles, F., Frias‐Lopez, J., Paster, B., & Haffajee, A. (2013) · Periodontology 2000 · doi:10.1111/prd.12010 · Cited by 357
Infection, Inflammation, and Bone Regeneration: a Paradoxical Relationship
Thomas, M. V., & Puleo, D. A. (2011) · Journal of Dental Research · doi:10.1177/0022034510393967 · Cited by 329
Etiology and Pathogenesis of Periodontal Diseases
Tatakis, D. N., & Kumar, P. S. (2005) · Dental Clinics of North America · doi:10.1016/j.cden.2005.03.001 · Cited by 306
Metadata
- Authors
- Williams, R. C., Jeffcoat, M. K., Howard Howell, T., Rolla, A., Stubbs, D., Teoh, K. W., Reddy, M. S., & Goldhaber, P.
- Venue
- Journal of Periodontology
- Publisher
- Wiley
- Published
- 1989-09
- Volume
- 60
- Issue
- 9
- Pages
- 485-490
- ISSN
- 0022-3492 (ISSN-L)
- 1943-3670
- OpenAlex
- W2102925914
- Cited by
- 222
- References
- 0
- FWCI
- 9.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Altering the Progression of Human Alveolar Bone Loss With the Non‐Steroidal Anti‐Inflammatory Drug Flurbiprofen. https://app.cochat.ai/papers/10.1902/jop.1989.60.9.485
- The paper
- Williams, R. C., Jeffcoat, M. K., Howard Howell, T., Rolla, A., Stubbs, D., Teoh, K. W., Reddy, M. S., & Goldhaber, P. (1989). Altering the Progression of Human Alveolar Bone Loss With the Non‐Steroidal Anti‐Inflammatory Drug Flurbiprofen. Journal of Periodontology. https://doi.org/10.1902/jop.1989.60.9.485
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.